Literature DB >> 28154899

Baseline increased 18F-fluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study.

Eun-Kyoung Park1, Kyoungjune Pak2, Ji-Heh Park1, Keunyoung Kim2, Seong-Jang Kim3, In-Joo Kim2, Geun-Tae Kim4, Seung-Geun Lee5.   

Abstract

The goal of this study was to demonstrate whether increased 18F-fluoride uptake lesions on positron emission tomography (PET) scan can predict new syndesmophyte development in patients with ankylosing spondylitis (AS). In 12 AS patients, 18F-fluoride PET and magnetic resonance imaging (MRI) was performed at baseline, and radiography was performed at baseline and the 2-year follow-up. The following data were recorded: the presence of increased 18F-fluoride uptake lesions on PET defined as an uptake greater than the uptake in the adjacent normal vertebral body; acute (type A) and advanced (type B) corner inflammatory lesions (CILs) and fat lesions on MRI; and syndesmophytes on radiography. Of 231 anterior vertebral corners without syndesmophyte at baseline, 13 type A CILs (5.5%), 2 type B CILs (0.9%), and 20 fat lesions (8.7%) on MRI and six increased fluoride uptake lesions (2.6%) on PET were observed. At the 2-year follow-up, 16 new syndesmophytes (6.9%) in eight AS patients (66.7%) occurred. New syndesmophytes developed significantly more frequently in anterior vertebral corners with increased 18F-fluoride uptake lesions (50%) or fat lesions (25%) at baseline than in those without such lesions (5.8 and 5.2%; p = 0.005 and p = 0.007, respectively). After adjusting confounding factors, baseline increased 18F-fluoride uptake lesions was independently associated with new syndesmophytes development (OR 13.8, 95% CI 1.5-124.3, p = 0.019). Fat lesions were also associated with new syndesmophytes formation. Our data suggest that 18F-fluoride PET may be applied to identify AS patients with high risk of future syndesmophyte formation.

Entities:  

Keywords:  Ankylosing spondylitis; Fluoride; Osteoblasts; Positron emission tomography

Mesh:

Year:  2017        PMID: 28154899     DOI: 10.1007/s00296-017-3660-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  40 in total

Review 1.  Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases.

Authors:  Yuxin Li; Christiaan Schiepers; Ralph Lake; Simin Dadparvar; Gholam R Berenji
Journal:  Bone       Date:  2011-10-06       Impact factor: 4.398

2.  Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.

Authors:  M Rudwaleit; X Baraliakos; J Listing; J Brandt; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2005-03-18       Impact factor: 19.103

3.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

4.  Fat metaplasia and backfill are key intermediaries in the development of sacroiliac joint ankylosis in patients with ankylosing spondylitis.

Authors:  Walter P Maksymowych; Stephanie Wichuk; Praveena Chiowchanwisawakit; Robert G Lambert; Susanne J Pedersen
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

5.  Hybrid 18F-labeled Fluoride Positron Emission Tomography/Magnetic Resonance (MR) Imaging of the Sacroiliac Joints and the Spine in Patients with Axial Spondyloarthritis: A Pilot Study Exploring the Link of MR Bone Pathologies and Increased Osteoblastic Activity.

Authors:  Christian Buchbender; Benedikt Ostendorf; Verena Ruhlmann; Philipp Heusch; Falk Miese; Karsten Beiderwellen; Matthias Schneider; Juergen Braun; Gerald Antoch; Xenofon Baraliakos
Journal:  J Rheumatol       Date:  2015-07-01       Impact factor: 4.666

6.  18F- fluoride PET/CT assessment in patients fulfilling the clinical arm of the ASAS criteria for axial spondyloarthritis. A comparative study with ankylosing spondylitis.

Authors:  Eric Toussirot; Cecile Caoduro; Constantin Ungureanu; Fabrice Michel; Michel Runge; Hatem Boulahdour
Journal:  Clin Exp Rheumatol       Date:  2015-06-08       Impact factor: 4.473

7.  Assessment of bone synthetic activity in inflammatory lesions and syndesmophytes in patients with ankylosing spondylitis: the potential role of 18F-fluoride positron emission tomography-magnetic resonance imaging.

Authors:  Seung-Geun Lee; In-Joo Kim; Keun-Young Kim; Hee-Young Kim; Kyoung-June Park; Seong-Jang Kim; Eun-Kyoung Park; Yun-Kyung Jeon; Byeong-Yun Yang; Geun-Tae Kim
Journal:  Clin Exp Rheumatol       Date:  2015-01-09       Impact factor: 4.473

8.  Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS).

Authors:  Joachim Sieper; Joachim Listing; Denis Poddubnyy; In-Ho Song; Kay-Geert Hermann; Johanna Callhoff; Uta Syrbe; Jürgen Braun; Martin Rudwaleit
Journal:  Ann Rheum Dis       Date:  2015-08-04       Impact factor: 19.103

9.  Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis.

Authors:  Heiner Appel; Christoph Loddenkemper; Zarko Grozdanovic; Harald Ebhardt; Marc Dreimann; Axel Hempfing; Harald Stein; Peter Metz-Stavenhagen; Martin Rudwaleit; Joachim Sieper
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  High-resolution [18F]fluoride positron emission tomography of the distal interphalangeal joint in psoriatic arthritis--a bone-enthesis-nail complex.

Authors:  Ai Lyn Tan; Steven F Tanner; Michael L Waller; Elizabeth M A Hensor; Alison Burns; Alan P Jeavons; Robert F Bury; Paul Emery; Dennis McGonagle
Journal:  Rheumatology (Oxford)       Date:  2013-01-09       Impact factor: 7.580

View more
  5 in total

1.  Serum CCL11 level is associated with radiographic spinal damage in patients with ankylosing spondylitis.

Authors:  Dong Hyun Sohn; Hoim Jeong; Jong Seong Roh; Han-Na Lee; Eunsung Kim; Jung Hee Koh; Seung-Geun Lee
Journal:  Rheumatol Int       Date:  2018-05-30       Impact factor: 2.631

Review 2.  The role of imaging in the diagnosis and management of axial spondyloarthritis.

Authors:  Walter P Maksymowych
Journal:  Nat Rev Rheumatol       Date:  2019-10-07       Impact factor: 20.543

Review 3.  Bone Involvement in Patients with Spondyloarthropathies.

Authors:  Willem Lems; Corinne Miceli-Richard; Judith Haschka; Andrea Giusti; Gitte Lund Chistensen; Roland Kocijan; Nicolas Rosine; Niklas Rye Jørgensen; Gerolamo Bianchi; Christian Roux
Journal:  Calcif Tissue Int       Date:  2022-01-23       Impact factor: 4.333

4.  Relationship between serum adipokine levels and radiographic progression in patients with ankylosing spondylitis: A preliminary 2-year longitudinal study.

Authors:  Ji-Heh Park; Seung-Geun Lee; Yun-Kyung Jeon; Eun-Kyoung Park; Young-Sun Suh; Hyun-Ok Kim
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

5.  Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography.

Authors:  Stefan T G Bruijnen; Nicki J F Verweij; Leonie M van Duivenvoorde; Nathalie Bravenboer; Dominique L P Baeten; Christiaan J van Denderen; Irene E van der Horst-Bruinsma; Alexandre E Voskuyl; Martijn Custers; Peter M van de Ven; Joost C J Bot; Bouke J H Boden; Adriaan A Lammertsma; Otto S H Hoekstra; Pieter G H M Raijmakers; Conny J van der Laken
Journal:  Rheumatology (Oxford)       Date:  2018-04-01       Impact factor: 7.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.